Treatment Response and Locoregional Control in Locally Advanced Oral Cavity Cancers with Concurrent Chemoradiation and Radiation Alone

Journal Title: Indian Journal of Cancer Education and Research - Year 2017, Vol 5, Issue 1

Abstract

Aim: To clinically determine the treatment response and locoregional control in locally advanced oral cavity cancers with concurrent chemoradiation and radiation alone. Materials and Methods: This study was carried out in department of Radiotherapy, MNJ Institute of Oncology & Regional Cancer Center, Hyderabad from October 2010 to April 2012. A total of 50 patients with histologically proven squamous cell carcinoma of oral cavity was enrolled in this study. In this prospective study, patients were randomized to receive either chemoradiation alone (arm –A) or radiotherapy alone (armB). Response rate & locoregional control are primary end points, toxicity profile and feasibility are secondary end points. Inclusion Criteria: Patients with age < 60 years, both sexes. Patients with histologically proven advanced squamous cell cancer of the oral cavity (stage III & IV). Karnofsky’s performance scale  70. Haematopoietic : Hemogram >10 gm /dl, Total WBC count > 6000/mm3 and Platelet count > 1,00,000/ mm. Renal: Serum creatinine 1.5 mg/dl (or) creatinine clearance 60 ml/min, Hepatic : Bilirubin  1.5 times upper limit of Normal (ULN), AST (or) ALT < 2 times of ULN. Alkaline phosphate  1.5 times ULN , Normal chest Xray. Exclusion Criteria: Patients with age above 60 years. History of previous treatment with any of the following modalities–Surgery, radiotherapy, chemotherapy. Patient with distant metastasis. Hemoglobin <10 gm%. Associated comorbid conditions: Untreated tuberculosis, Uncontrolled diabetes mellitus and Uncontrolled Hypertension. Results: In this prospective study conducted from October 2010 to April 2012, a total of 50 patients proven cases of squamous cell carcinoma of oral cavity were enrolled, 25 patients in chemoradiation (armA) and 25 in radiotherapy alone (armB). Out of which 2 patient dropped out in armA. 23 patients in chemoradiation arm received cisplatin 40 mg/m2/ week for 6 cycles with Radiotherapy (66 Gy in 33 Fr 2 Gy/Fr, 5 days in a week) and 25 patients in radiation alone arm received 66 Gy in 33 Fr 2 Gy/Fr, 5 days in a week. There was good balance in prognostic factors, including performance status, tumor and nodal stages and histology between the two arms. buccal mucosa is predominant site of distribution in both arms. TNM Stage in armA, among 23 patients, 8 were in stage III and 11, 4 in stage IVA and IV B and in armB, out of 25patients, 8 in stage III and 13, 4 in stage IV A and IV B, respectively with a probability value (P=0.94) for stage. All the 100% patients in both arms completed the radiation procol that is 66 Gy in 33 Fr 2 Gy/Fr, 5 days in a week for 6.5 weeks. In armB (n=23), when compliance to chemotherapy considered, majority completed 6 cycles of chemotherapy. 87% (20/23) patients completed the full course of 6 cycles of chemotherapy. Only 13%(3/23) patients received cycles of chemotherapy. The complete response of primary tumor with T3 stage in chemoradiation arm was seen in 65%(5/8)and partial response in 35% (3/8) of the patients. The corresponding figures in the radiation alone arm were 50%(4/8) and 50% (4/ 8) respectively. The complete response seen in patients with T4a and T4b tumors in chemoradiation arm was 45%(5/11), 30%(1/4) and partial response was 55%(6/11) , 70%(3/4) while in the radiation alone arm, it is 35%(5/13), 20% complete response and 65% (8/13). 80% partial response. The median time to response from the end of the radiation was 3 months. Conclusion: Despite statistical insignificance locoregional control (tumor response) is superior (numerical benefit) with concurrent chemoradiation as compared to radiotherapy alone in locally

Authors and Affiliations

Anice Fathima

Keywords

Related Articles

Clinical Profile and Therapy of Hepatocelluar Carcinoma at a Tertiary Care Institute from South India: A Retrospective Study of 182 Patients

Objective: To study the clinical profile and therapy of hepatocellular carcinoma (HCC) at a tertiary care institute in Andhrapradesh, Southindia. Methods: Data analysis of HCC patients enrolled in between 2000 and 2015....

Treatment Response and Locoregional Control in Locally Advanced Oral Cavity Cancers with Concurrent Chemoradiation and Radiation Alone

Aim: To clinically determine the treatment response and locoregional control in locally advanced oral cavity cancers with concurrent chemoradiation and radiation alone. Materials and Methods: This study was carried out i...

Study of Heart Rate and Blood Pressure Response to Isometric Leg Press Exercise Test in Obese Young Male Adults

Background and Objectives: Assessment of Cardiovascular sympathetic activity in obese and Normal young adults by recording Heart rate and blood pressure. The study was done to assess the effect of isometric Leg press exe...

A Comparative Analysis of Acute Toxicities in Hypofractionated Radiotherapy Vs Standard Fractionation in Early Breast Cancer Post Breast Conservation Therapy

Aim: The aim of the present study is to compare the acute toxicities between the accelerated course of hypo fractionated whole breast irradiation and conventional standard fractionation of Radiotherapy. Objectives: To de...

Carcinoma Cervix with Extensive Scar Site Metastasis after Simple Hysterectomy: A Rare Scenario

Recurrences after surgery or radiation for Carcinomas of uterine cervix are most commonly locoregional with the parametrium, lymph nodes and vagina as the most frequent sites of relapse. The occurrence of scar site metas...

Download PDF file
  • EP ID EP459974
  • DOI 10.21088/ijcer.2321.9815.5217.1
  • Views 84
  • Downloads 0

How To Cite

Anice Fathima (2017). Treatment Response and Locoregional Control in Locally Advanced Oral Cavity Cancers with Concurrent Chemoradiation and Radiation Alone. Indian Journal of Cancer Education and Research, 5(1), 53-60. https://europub.co.uk/articles/-A-459974